Recruiting OBSERVATIONAL NCT06716242
Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters (iPregnostic)
Prospective, Observational, Multicentre Study to Confirm the Performance of Molecular Screening for Early Detection of Preeclampsia
Sponsor: iPremom
Conditions
Preeclampsia (PE)
Interventions
Peripheral blood collection
Updated 3 times since 2025 Last updated: Mar 21, 2025 Primary completion: Feb 28, 2027 Completion: Feb 28, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Preeclampsia (PE), this trial is actively recruiting participants. The trial is conducted by iPremom and has accumulated 3 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Apr 2025 — Sep 2025 [monthly]
Recruiting
-
Jan 2025 — Apr 2025 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- iPremom
Data source: iPremom
For direct contact, visit the study record on ClinicalTrials.gov .